Malignant neoplasm of the skin Basal cell carcinoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients of both sexes; over 18 years of age; patients with malignant Nodular Basal Cell Carcinoma lesions with a maximum diameter of 1 (one) centimeter. Patients with multiple lesions may also be treated, as long as each lesion meets the characteristics described in the previously.
Exclusion criteria
Exclusion criteria: Patients with allergy to any of the excipients present in the formula; Infiltrative Basal Cell Carcinoma, Micro-infiltrative, Sclerodermiform and plano-cicatricial, Terebrant histological subtype, as well as Squamous Cell or Epidermoid Carcinoma and Melanoma; Patients with porphyria; Nodular Basal Cell Carcinoma lesions larger than 1 cm in diameter; Under 18 years of age; Pregnant and lactating women; Women of childbearing age; Photosensitive diseases, for example, Lupus.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine whether the proposed single-visit Sono-Photodynamic Therapy protocol improves the cure rate of single-visit Photodynamic Therapy in Nodular Basal Cell Carcinoma within 30 days. | — |
Secondary
| Measure | Time frame |
|---|---|
| Compare recurrence for both protocols through clinical and histopathological evaluation after 6 months of treatment. - Evaluate the aesthetic results and pain score associated with both protocols. - Evaluate patient preference regarding the modality: Photodynamic Therapy or Sono-Photodynamic Therapy. | — |
Countries
BR
Contacts
Hospital Amaral Carvalho